7/24 Canlı Destek
ÖZEL YÜZYIL HASTANESİ

Doç. Dr. Aysun TOKER

Pendik Hastanemiz

Biyokimya

RANDEVU AL

Eğitim:

Lisans

 Tıp Fakültesi

Ege  Üniversitesi

1999

Tıpta Uzmanlık

Biyokimya ve Klinik Biyokimya

Şişli Etfal Eğitim ve Araştırma Hastanesi

2003

Doktora

 Biyokimya

Atatürk Üniversitesi, Sağlık Bilimleri Enstitüsü

2008

Akademik Unvanlar:

Yardımcı Doçentlik Tarihi : Nisan 2011           

Doçentlik Tarihi                : Ekim 2013

.     Yönetilen Yüksek Lisans ve Doktora Tezleri

      6.1.  Yüksek Lisans Tezleri: Ankilozan spondilit hastalarında serum endokan düzeyleri

      6.2.  Tıpta Uzmanlık Tezleri: Kronik böbrek ve renal transplant hastalarında decoy reseptör 3 ün inflamasyon ve aterosklerozdaki rolü

7.     Yayınlar

      7.1.  Uluslararası hakemli dergilerde yayınlanan makaleler (SCI & SSCI & Arts and Humanities)

      1. Demir I, Toker A, Aksoy H, Tasyurek E, Zengin S. The Impact of Shift Type on Oxidative Stress, Inflammation and Platelet Activation. J Occup Environ Med. 2021;63(3):e127-e131.
      2. Kural A, Tekin Neijmann S, Toker A, Doğan H, Sever N, Sarıkaya S. Evaluation of rat major celluler prion protein for early diagnosis in experimental rat brain trauma model. Ulus Travma Acil Cerrahi Derg. 2020;26(1):1-8.
      3. Uslu AU, Kucuk A, Balta S, Ozturk C, Arslan S, Tekin L, Kucuksen S, Toker A, Kayrak M. The relation between ischemia modified albumin levels and carotid intima media thickness in patients with rheumatoid arthritis. Int J Rheum Dis. 2019;22(1):32-37.
      4. Can U, Uysal S, Ugur RA, Toker A, Aslan U, Hidayetoglu TB. Can YKL-40 be an Inflammatory Biomarker in Vitamin D Deficiency? Int J Vitam Nutr Res. 2019;89(5-6):309-313.
      5. Konak M, Minici M, Tarakcı N, Altunhan H, Toker A, Ors R. Effects of the storage of breast milk at different temperatures on total antioxidant capacity, total oxidant status, and paraoxonase-1 level. Turk J Pediatr. 2019;61(1):1-6.
      6. Isık U, Bilgic A, Toker, Kılınc I. Serum levels of cortisol, dehydroepiandrosterone, and oxytocin in children with attention-deficit/hyperactivity disorder combined presentation with and without comorbid conduct disorder. Psychiatry Res. 2018;261:212-219.
      7. Ozer EK, Goktas MT, Toker A, Bariskaner H, Ugurluoglu C, Iskit AB. Effects of Carvacrol on Survival, Mesenteric Blood Flow, Aortic Function and Multiple Organ Injury in a Murine Model of Polymicrobial Sepsis. Inflammation. 2017;40(5):1654-1663.
      8. Ozer EK, Goktas MT, Toker A, Pehlivan S, Bariskaner H, Ugurluoglu C, Iskit AB. Thymoquinone protects against the sepsis induced mortality, mesenteric hypoperfusion, aortic dysfunction and multiple organ damage in rats. Pharmacol Rep. 2017;69(4):683-690.
      9. Ozer EK, Goktas MT, Kilinc I, Toker A, Bariskaner H, Ugurluoglu C, Iskit AB. Infliximab alleviates the mortality, mesenteric hypoperfusion, aortic dysfunction, and multiple organ damage in septic rats. Can J Physiol Pharmacol. 2017;95(7):866-872.
      10. Konak M, Tarakci N, Altunhan H, Annagür A, Toker A, Örs R. Total antioxidant, total oxidant and serum paraoxonase levels according to lipid administration method in parenterally fed premature infants. J Matern Fetal Neonatal Med. 2017;30(14):1734-1738.
      11. Bilgiç A, Toker A, Işık Ü, Kılınç İ. Serum brain-derived neurotrophic factor, glial-derived neurotrophic factor, nerve growth factor, and neurotrophin-3 levels in children with attention-deficit/hyperactivity disorder. Eur Child Adolesc Psychiatry. 2017;26(3):355-363.
      12. Koc S, Kıyıcı H, Toker A, Soyalıç H, Aslan H, Kesici H, Karaca ZI. The effect of melatonin and vitamin C treatment on the experimentally induced tympanosclerosis: study in rats. Braz J Otorhinolaryngol. 2017;83(5):541-545.
      13. Kucuk A, Uğur Uslu A, Icli A, Cure E, Arslan S, Turkmen K, Toker A, Kayrak M.The LDL/HDL ratio and atherosclerosis in ankylosing spondylitis. Z Rheumatol. 2017;76(1):58-63.
      14. Bilgiç A, Toker A, Uysal S. An exploratory study to evaluate the plasma vasopressin and apelin - 13 levels in children with attention-deficit/hyperactivity disorder. Psychiatry Clin Neurosci. 2016;70(10):442-447.
      15. Bilgiç Ö, Sivrikaya A, Toker A, Ünlü A, Altınyazar C. Serum levels of TWEAK in patients with psoriasis vulgaris. Cytokine. 2016;77:10-3.
      16. Cakir OO, Esen H, Toker A, Ataseven H, Demir A, Polat H. Effects of diclofenac sodium and octreotide on treatment of caerulein-induced acute pancreatitis in mice. Int J Clin Exp Med. 2015;8(10):17551-17564.
      17. Uysal S, Toker A, Akçay M, Gökçe HR. Ischemia modified albumin Changes During OGTT in Pregnant Women with Gestational Diabetes Mellitus. Clin Invest Med 2015;38(4):E38-E44.
      18. Karatas Y, Cengiz SL, Esen H, Toker A, Savas C. Effect of Carvedilol on Secondary Damage in Experimental Spinal Cord Injury in Rats. Turk Neurosurg. 2015;25(6):930-935.
      19. Uguz F, Kucuk A, Aydogan S, Arslan S, Kurt HG, Toker A, Sahin M. Is major depression associated with serum levels of tumor necrosis factor-alpha in patients with rheumatoid arthritis? J Psychosom Res. 2015;79(6):530-532.
      20. Demir I, Toker A, Zengin S, Laloglu E, Aksoy H. Oxidative stress and insulin resistance in policemen working shifts. Int Arch Occup Environ Health. 2016;89(3):407-412.
      21. Mehmetoglu I, Kurban S, Toker A, Annagür A, Altunhan H, Erbay E, Ors R. Serum IMA and oxidized LDL levels in cord blood and serum of neonates born to preeclamptic mothers. Pediatr Int 2015;57(3):422-426.
      22. Gaipov A, Solak Y, Turkmen K, Toker A, Baysal AN, Cicekler H, Biyik Z, Erdur FM, Kilicaslan A, Anil M, Gormus N, Tonbul HZ, Yeksan M, Turk S. Serum uric acid may predict development of progressive acute kidney injury after open heart surgery. Ren Fail 2015;37(1):96-102.
      23. Yerlikaya F, Toker A, Ciçekler H, Arıbaş A. The association of total sialic acid and malondialdehyde levels with metabolic and anthropometric variables in obesity. Biotech Histochem 2015;90(1):31-37.
      24. Aksoy AN, Toker A, Celik M, Aksoy M, Halici Z, Aksoy H. The effect of progesterone on systemic inflammation and oxidative stress in the rat model of sepsis. Indian J Pharmacol 2014:46;622-626.
      25. Toker A, Kucuksen S, Kucuk A, Cicekler H. Serum Ischemia-Modifed Albumin and Malondialdehyde Levels and Superoxide Dismutase Activitiy in Patients with Fibromyalgia. Clin Lab 2014;60:1609-1615.  
      26. Erdem SS, Toker A, Kayrak M, Cicekler H, Gonulalan G, Abdulhalikov T, Yerlikaya FH, Kaya A. Oxidant and antioxidant parmeters in prediabetes and diabetes. Int J Diabetes Dev Countries 2015;35(3):465-470.  
      27. Doseyici S, Mehmetoglu I, Toker A, Yerlikaya F, Erbay E. The effects of forskolin and rolipram on cAMP, cGMP and free fatty acid levels in diet induced obesity. Biotech Histochem 2014;89(5):388-392.
      28. Toker A, Karatas Z, Altın H, Karaarslan S, Cicekler H, Alp H. Evaluation of Serum Ischemia Modified Albumin Levels in Acute Rheumatic Fever Before and After Therapy. Indian J Pediatr 2014;81(2):120-125.
      29. Turkmen K, Tonbul HZ, Erdur FM, Toker A, Biyik Z, Ozbiner H, Gaipov A, Gul EE, Kayrak M, Solak Y, Ozbek O, Turk S, Covic A. Soluble TWEAK independently predicts atherosclerosis in renal transplant patients. BMC Nephrol 2013:12;14:144.
      30. Toker A, Aribas A, Yerlikaya FH, Tasyurek E, Akbuğa K. Serum and saliva levels of ischemia-modified albumin in patients with acute myocardial infarction. J Clin Lab Anal 2013;27(2):99-104.
      31. Turkmen K, Erdur FM, Guney I, Ozbiner H, Toker A, Gaipov A, Ozbek O, Yeksan M, Tonbul HZ, Turk S. Relationship between Plasma Pentraxin-3, Neutrophil-to-Lymphocyte Ratio, and Atherosclerosis in Renal Transplant Patients. Cardiorenal Med 2012;2(4):298-307.
      32. Toker A, Yerlikaya F, Yener Y, Toy H. Serum homocysteine, arginine, citrulline and asymmetric dimethyl arginine levels, and histopathologic examination of the abdominal aorta in rats exposed to acrylamide. Biotech Histochem. 2013;88(2):103-108.
      33. Karatas Z, Baysal T, Alp H, Toker A. Serum Tenascin-C: A Novel Biomarker for Diagnosis and Predicting Prognosis of Rheumatic Carditis? J Trop Pediatr 2013;59(6):476-482.
      34. Yerlikaya FH, Toker A, Aribas A. Serum trace element status of diabetic and nondiabetic morbid obese females. Indian J Med Res 2013;137(2):339-345.
      35. Toker A, Ziypak T, Orsal , Laloglu E, Bedi F, Aksoy Y. Is Urinary Kidney Injury Molecule-1 a Noninvasive Marker for Renal Scarring in Children With Vesicoureteral Reflux?. Urology 2013;81(1):168-172.
      36. Toker A, Mehmetoglu I, Yerlikaya FH, Nergiz S, Kurban S, Gok H. Investigation of Oxidative Stress Markers in Essential Hypertension. Clin Lab 2013;59(1-2):107-114.
      37. Toker A, Akcay F, Aksoy H, Suleyman H, Ozgen U, Erdem H. The effects of "acetyl shikonin" isolated from onosma armeniacum on oxidatıve stress in ethanol- induced ulcer model of rats. Turk J Med Sci 2013;43:315-320.
      38. Turkmen K, Tonbul HZ, Toker A, Gaipov A, Erdur FM, Cicekler H, Anil M, Ozbek O, Selcuk NY, Yeksan M, Turk S. The Relationship between Oxidative Stress, Inflammation, and Atherosclerosis in Renal Transplant and End-Stage Renal Disease Patients. Ren Fail 2012;34(10):1229-1237.
      39. Akcay A, Nguyen Q, He Z, Turkmen K, Won Lee D, Hernando AA, Altmann C, Toker A, Pacic A, Ljubanovic DG, Jani A, Faubel S, Edelstein CL. IL-33 exacerbates acute kidney injury. J Am Soc Nephrol. 2011 Nov;22(11):2057-2067.
      40. Ozden H, Kabay SC, Toker A, Ustüner MC, Ozbayer C, Ustüner D, Günes HV. The effects of levetiracetam on urinary 15f-2t-isoprostane levels in epileptic patients. Seizure. 2010;19(8):514-16.
      41. Gulcan E, Taser F, Toker A, Korkmaz U, Alcelik A.Increased Frequency of Prediabetes in Patients With Irritable Bowel